Related Experiment Video
Updated: May 12, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Management of NSAID-associated upper gastrointestinal problems
1Department of Digestive Diseases, Dallas VA Medical Center, TX 75216, USA. byron.cryer@UTSouthwestern.edu
Nonsteroidal anti-inflammatory drug (NSAID) use can lead to serious gastrointestinal (GI) events. Primary care clinicians can prevent these life-threatening issues by understanding risk factors and using gastroprotective agents.
Area of Science:
- Gastroenterology
- Pharmacology
- Internal Medicine
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed globally.
- NSAID use is associated with significant gastrointestinal (GI) adverse events, which can be life-threatening.
- Serious GI events often present with minimal warning signs.
Purpose of the Study:
- To identify key risk factors for NSAID-related GI adverse events.
- To review and recommend appropriate management and prevention strategies for clinicians.
- To emphasize the role of primary care in mitigating NSAID-induced GI complications.
Main Methods:
- Literature review of risk factors associated with NSAID-induced GI events.
- Analysis of current management and prevention strategies.
- Synthesis of evidence for clinical practice guidelines.
Main Results:
- Identified risk factors include advanced age, history of GI ulceration or bleeding, and concurrent medication use.
- Under-recognized risk factors include polypharmacy with NSAIDs (including low-dose aspirin) and Helicobacter pylori infection.
- Gastroprotective agents are effective in preventing serious NSAID-related GI complications.
Conclusions:
- Primary care clinicians play a crucial role in preventing serious NSAID-related GI events.
- Awareness of risk factors and proactive management are essential for patient safety.
- Timely intervention and the use of gastroprotective measures can avert severe outcomes.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drugs for Treatment of Ulcerative Colitis in IBD
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...